Milestone pharmaceuticals inc. (MIST)

CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Operating activities
Net loss for the period

-61,120

-55,229

-46,656

-39,526

-29,456

-23,185

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of property and equipment

59

38

16

10

11

10

0

0

0

Share-based compensation expense (note 4)

1,961

1,191

1,181

916

719

633

0

0

0

Changes in operating assets and liabilities:
Other receivables

10

-119

367

153

118

271

0

0

0

Research and development tax credits receivable

420

288

229

177

-44

-137

0

0

0

Prepaid expenses

-3,933

447

2,048

4,589

4,754

1,298

0

0

0

Operating lease right of use asset, net

0

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

1,264

3,520

6,253

4,373

2,440

2,876

0

0

0

Income taxes payable (receivable)

-

-56

1

0

58

52

0

0

0

Net cash used in operating activities

-54,498

-51,152

-41,860

-39,153

-31,056

-21,046

0

0

0

Investing activities
Acquisition of property and equipment

-

-

-

-

-

5

0

0

0

Redemption of short-term investments

-

-

-

-

-

19,032

0

0

0

Net cash (used in) provided by investing activities

-

-

-

-

-

15,998

0

0

0

Financing activities
Issuance of common shares on exercise of share options (note 4)

96

44

449

449

456

461

0

0

0

Net cash provided by financing activities

85,459

85,407

165,464

166,195

80,110

80,115

0

0

0

Net increase in cash and cash equivalents during the period

30,577

33,871

102,306

93,021

58,056

75,067

0

0

0